Author: BELLMONT PARTNERS

Posted Date:

March 30, 2026

Head and Neck Cancer Foundation to host free walk-in oral cancer screening exams across the country in recognition of Head and Neck Cancer Awareness Week

BELLMONT PARTNERS

March 30, 2026
Monteris Medical Secures $28 Million in Growth Equity to Accelerate Revenue and Innovation in Minimally Invasive Neurosurgery

BELLMONT PARTNERS

March 12, 2026
Verve Medical Treats First Patient in Landmark U.S. Pilot Trial for Uncontrolled Hypertension, Advancing Momentum from Breakthrough TUSK Results

BELLMONT PARTNERS

March 11, 2026
INDEPENDENT REVIEW PUBLISHED IN JOURNAL OF ULTRASOUND MEDICINE STRONGLY SUPPORTS THE INTEGRAL ROLE OF ULTRASOUND IN CARPAL TUNNEL SYNDROME TREATMENT

BELLMONT PARTNERS

March 11, 2026
Monteris Medical Announces New Study Showing NeuroBlate® Laser Ablation May Enhance Immunotherapy Response, Providing Significant Overall Survival Improvement in Recurrent High Grade Brain Tumors

BELLMONT PARTNERS

March 4, 2026
Airiver Medical Granted FDA’s Breakthrough Device Designation for Pulmonary Drug Coated Balloon to Treat Central Airway Stenosis; First Patient Treated in Clinical Trial

BELLMONT PARTNERS

March 4, 2026
MISSION REGISTRY DATA CONFIRM ULTRASOUND-GUIDED CARPAL TUNNEL RELEASE OFFERS DISTINCT ADVANTAGES OVER ENDOSCOPIC CARPAL TUNNEL RELEASE

BELLMONT PARTNERS

March 3, 2026
/C O R R E C T I O N — Monteris Medical/

BELLMONT PARTNERS

February 3, 2026
Monteris Medical Leads Effort to Secure TRICARE Coverage for Laser Interstitial Thermal Therapy (LITT) for Military Members

BELLMONT PARTNERS

January 28, 2026
SONEX HEALTH ANNOUNCES PUBLICATION OF LARGEST MULTI-CENTER STUDY COMPARING ULTRASOUND-GUIDED CARPAL TUNNEL RELEASE TO OPEN CARPAL TUNNEL RELEASE

BELLMONT PARTNERS

January 27, 2026